Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,072 | 802 | 99.3% |
| Education | $102.82 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,151 | 123 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,937 | 86 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,057 | 51 | $0 (2022) |
| PFIZER INC. | $996.75 | 65 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $925.45 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $885.79 | 50 | $0 (2022) |
| GlaxoSmithKline, LLC. | $695.85 | 57 | $0 (2024) |
| Lilly USA, LLC | $580.27 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $558.25 | 19 | $0 (2018) |
| Astellas Pharma US Inc | $513.52 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,295 | 50 | AstraZeneca Pharmaceuticals LP ($503.22) |
| 2023 | $1,465 | 61 | Lilly USA, LLC ($269.82) |
| 2022 | $1,433 | 70 | Novo Nordisk Inc ($263.88) |
| 2021 | $1,610 | 65 | AstraZeneca Pharmaceuticals LP ($273.07) |
| 2020 | $1,766 | 117 | AstraZeneca Pharmaceuticals LP ($311.51) |
| 2019 | $2,669 | 154 | Novo Nordisk Inc ($394.50) |
| 2018 | $2,590 | 140 | Novo Nordisk Inc ($373.45) |
| 2017 | $2,348 | 151 | Novartis Pharmaceuticals Corporation ($417.20) |
All Payment Transactions
808 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.76 | General |
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $118.53 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Diabetes Care | ||||||
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardio-renal | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Inflammation | ||||||
| 07/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Diabetes | ||||||
| 06/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Diabetes Care | ||||||
| 06/05/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,461 | 3,382 | $258,615 | $93,013 |
| 2022 | 26 | 3,008 | 3,833 | $277,703 | $98,931 |
| 2021 | 29 | 3,183 | 4,102 | $284,132 | $104,029 |
| 2020 | 29 | 3,166 | 4,033 | $285,288 | $86,196 |
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 171 | 329 | $47,705 | $17,657 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 144 | 144 | $30,960 | $17,103 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 314 | $43,960 | $16,408 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 161 | $33,005 | $12,121 | 36.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 145 | $11,600 | $5,215 | 45.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 186 | 258 | $13,932 | $3,303 | 23.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 175 | 196 | $12,740 | $3,226 | 25.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 195 | 276 | $9,936 | $2,846 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 196 | 275 | $5,500 | $2,293 | 41.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 161 | 219 | $8,760 | $2,025 | 23.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 30 | 56 | $4,760 | $1,883 | 39.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 178 | 223 | $7,359 | $1,697 | 23.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 41 | $3,485 | $1,281 | 36.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 76 | 76 | $2,280 | $1,264 | 55.4% |
| 84550 | Uric acid level, blood | Office | 2023 | 174 | 181 | $3,620 | $786.62 | 21.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 40 | 40 | $2,600 | $756.80 | 29.1% |
| 83735 | Magnesium level | Office | 2023 | 102 | 109 | $3,270 | $705.34 | 21.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 17 | $1,564 | $651.61 | 41.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 86 | 155 | $2,325 | $478.65 | 20.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 28 | 28 | $1,680 | $413.84 | 24.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 12 | $900.00 | $331.21 | 36.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 14 | 14 | $910.00 | $234.26 | 25.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 84 | 85 | $1,020 | $181.26 | 17.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $744.00 | $126.00 | 16.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 16 | 16 | $4,000 | $24.70 | 0.6% |
About Dr. Ralph Taylor, MD
Dr. Ralph Taylor, MD is a Internal Medicine healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417005711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Taylor, MD has received a total of $15,175 in payments from pharmaceutical and medical device companies, with $1,295 received in 2024. These payments were reported across 808 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($15,072).
As a Medicare-enrolled provider, Taylor has provided services to 11,818 Medicare beneficiaries, totaling 15,350 services with total Medicare billing of $382,169. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Memphis, TN
- Active Since 01/05/2007
- Last Updated 02/27/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417005711
Products in Payments
- Ozempic (Drug) $841.26
- FARXIGA (Drug) $824.07
- JARDIANCE (Drug) $703.08
- ENTRESTO (Drug) $558.25
- XARELTO (Drug) $519.65
- Kerendia (Drug) $390.13
- BREZTRI (Drug) $375.33
- INVOKANA (Drug) $366.14
- JANUVIA (Drug) $363.47
- NEXLIZET (Drug) $338.51
- Victoza (Drug) $332.55
- MYRBETRIQ (Drug) $331.65
- Rybelsus (Drug) $324.11
- ELIQUIS (Drug) $313.16
- Tresiba (Drug) $311.68
- CHANTIX (Drug) $309.15
- AIRSUPRA (Drug) $302.10
- SOLIQUA 100/33 (Biological) $283.97
- TRELEGY ELLIPTA (Drug) $279.04
- TOUJEO (Drug) $269.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Memphis
Patricia Adams-Graves, Md, MD
Internal Medicine — Payments: $275,584
Phillip Northcross, M.c, M.C
Internal Medicine — Payments: $88,005
Dr. William Cushman, Md, MD
Internal Medicine — Payments: $74,181
Dr. Rajesh Kabra, Md, MD
Internal Medicine — Payments: $50,656
Dr. Pedro Velasquez, Md, MD
Internal Medicine — Payments: $44,386
Saurin Chokshi
Internal Medicine — Payments: $43,695